Marketing authorisation (veterinary medicines)
Marketing authorisation (veterinary medicines)
Page update history
See update history 19 August 2026 Steps involved in obtaining an EU marketing authorisation updated to reflect the migration of veterinary regulatory business services from ServiceNow to the IRIS platform.
Related content
Veterinary medicines: regulatory information Research and development (veterinary medicines) Post-authorisation (veterinary medicines) Fees payable to the European Medicines Agency Maximum residue limits (MRL) Pharmacovigilance (veterinary medicines) Support to SMEs
Related EU legislation
EudraLex - Volume 5 - Pharmaceutical legislation for medicinal products for veterinary use EudraLex - Volume 6 - Notice to applicants and regulatory guidelines for medicinal products for veterinary use
External links
Veterinary eSubmission website
Contact point
Veterinary applications team Tel. +31 (0)88 781 6000 Link to Veterinary Regulatory Service Now
Topics
Regulatory and procedural guidance
Summary
The European Medicines Agency (EMA) is responsible for the scientific evaluation of centralised marketing authorisation applications (MAA). Once granted by the European Commission, the centralised marketing authorisation is valid in all European Union (EU) Member States, Iceland, Norway and Liechtenstein.